Maravai LifeSciences Holdings, Inc. MRVI Fair value of contingent consideration liability recorded in connection with acquisition of a business
Fair value of contingent consideration liability recorded in connection with acquisition of a business at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept mrvi:NoncashBusinessCombinationContingentConsiderationArrangementsLiability.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s fair value of contingent consideration liability recorded in connection with acquisition of a business.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s fair value of contingent consideration liability recorded in connection with acquisition of a business?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported fair value of contingent consideration liability recorded in connection with acquisition of a business of $0 in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s fair value of contingent consideration liability recorded in connection with acquisition of a business changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s fair value of contingent consideration liability recorded in connection with acquisition of a business decreased by 100.0% year-over-year, from $4.8M to $0.
- What does fair value of contingent consideration liability recorded in connection with acquisition of a business mean?
- This metric represents the estimated fair value of potential future payments to sellers of acquired businesses, contingent upon the achievement of specific performance milestones or financial targets. It reflects the non-cash adjustment to liabilities recognized on the balance sheet as part of purchase price accounting for acquisitions. Monitoring this figure provides insight into the company's inorganic growth strategy and the potential future cash obligations tied to the success of integrated business units.